Johnson & Johnson stock remains below resistance with MACD signaling a sell: weekly analysis

Traders Union
All News
Stocks
Johnson & Johnson slips 1.07% this week

Highlights

Shares of Johnson & Johnson closed at $253.24, falling 1.07% over the past seven days and remaining below short-term moving averages.
Oscillators and momentum indicators currently show short-term bearish momentum and an oversold reading, while long-term trends remain intact.
Price action is expected to consolidate within a $248.41 to $257.43 range, with immediate support at $251.28 and resistance at $260.66.

Dividend hike and year-over-year growth support sentiment despite patent risks

Johnson & Johnson demonstrated its commitment to shareholder returns by raising its quarterly dividend for the 64th consecutive year to $1.34 per share, according to 24/7 Wall St. The company also reported 6.6% year-over-year sales growth in the second quarter of 2026, even amid patent-related headwinds for STELARA, as highlighted by Seeking Alpha. An SEC filing further showed that Eastern Bank added 153,938 shares of JNJ to its portfolio as of September 30, 2026, according to Quiver Quantitative.

Narrow trading range persists as momentum shifts to short-term bearish

On the daily chart, Johnson & Johnson stock is displaying a flat trend with momentum reflecting a contained move within a narrow range as volatility touched 3.73% for the week. The MACD signals a Sell while the CCI reading of -105.23 places the stock in the oversold zone, highlighting short-term bearish momentum in contrast to a neutral RSI. Immediate support sits at $251.28, with resistance up at $260.66, while the Ichimoku Kijun at $265.07 acts as an added resistance barrier. This mix of oversold and neutral readings alongside contained momentum suggests the stock may remain under pressure but could stabilize above support.

Consolidation expected in the coming week unless key levels break

For the next five trading days, the expected range is $248.41 to $257.43. There is a 50% probability of an increase and a 50% probability of a decrease. The base case is continued consolidation inside this range. A sustained move above $260.66 would open a bullish scenario, while a drop below $251.28 would shift the bias further bearish.

Jainam Mehta, market strategist, notes that shares of Johnson & Johnson extended their slide this week and are now showing oversold daily conditions, though momentum loss appears contained. He sees the mix of technical signals — a flat trend with MACD Sell, CCI at -105.23, and neutral RSI — as supporting a base case for stabilization above near-term support at $251.28. Mehta also highlights that the company raised its dividend for the 64th straight year and reported robust 6.6% sales growth despite patent headwinds, with Eastern Bank increasing its stake, which may underpin investor sentiment. "I am watching for consolidation between $248.41 and $257.43 in the coming week, with a breakout above $260.66 required to shift the tactical bias upward."

Earlier, analysts noted that Johnson & Johnson shares were consolidating with mixed technical signals and uncertainty regarding the near-term direction. The current article confirms this ongoing consolidation bias, with prevailing downside risk centered on the $251.28 support level as traders await a decisive move outside the $248.41 to $257.43 range.

Source of Data: JNJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.